March 31, 2025 8:22 AM EDT | Source: Neural Therapeutics Inc.
Toronto, Ontario–(Newsfile Corp. – March 31, 2025) – Neural Therapeutics Inc. (CSE: NURL) (FSE: M6B) (“Neural”
or the “Company“), an ethnobotanical drug discovery company dedicated to developing therapeutic drugs for mental illnesses related to substance use disorders, is pleased to announce that shares of the company have commenced trading on the Frankfurt Stock Exchange under ticker symbol “M6B“.
Neural CEO Ian Campbell commented, “Listing our shares on a Frankfurt Stock Exchange will provide us with access to an expanded international investor audience, which we expect to lead to greater liquidity and an internationally diversified shareholder base as we continue to expand our operations. Furthermore, considering our proposed acquisition of Hanf.com, as outlined in our press release dated Oct 3, 2024, we expect that a Frankfurt listing will also serve as a…
